z-logo
open-access-imgOpen Access
In silico studies of isatinyl-2-aminobenzoylhydrazone transition metal complexes against cyclin-dependent kinase 6 (CDK6)
Author(s) -
Yesaya Reformyada Nusantoro,
Arif Fadlan
Publication year - 2021
Publication title -
pharmacy reports
Language(s) - English
Resource type - Journals
ISSN - 2798-9798
DOI - 10.51511/pr.4
Subject(s) - protein data bank (rcsb pdb) , cyclin dependent kinase 6 , chemistry , kinase , docking (animal) , in silico , biochemistry , lipinski's rule of five , stereochemistry , cyclin dependent kinase 2 , protein kinase a , medicine , nursing , gene
Cyclin-dependent kinase 6 (CDK6) is an important member of protein kinases, involving in many cellular pathways especialy cell cycle progression. Thus, CDK6 is a promising target in cancer therapy. This report aims to predict inhibiton of CDK6 by some complex compounds by using molecular docking and pharmacological properties analysis. Those compounds are isatinyl-2-aminobenzoylhydrazone (ISABH) and cobalt (II), nickel (II), copper (II), and zinc (II) transition metal complexes. The molecular docking against CDK6 (PDB code: 3NUP) revealed that ISABH/ISABH-transition metal complexes established ligand-protein interaction as expressed by negative binding affinity values. Drug-likeness by SwissADME indicated that ISABH and Ni-ISABH met the Lipinski’s rule of five. Both compounds also showed reasonable pharmacological criteria by admetSAR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here